Albert R. Collinson, Ph.D.
Login to view DISC.Albert Collinson is a seasoned biopharmaceutical executive with over 35 years of experience leading companies in the development and commercialization of novel therapeutics. He currently serves on the boards of Harbour BioMed and Privo Technologies. His peers recognize him as a charismatic leader, skilled scientist, and a great negotiator with a deep knowledge of the biopharma business.
He holds a Ph. D. in Biochemistry from Brandeis University and dual Bachelor of Science degrees from the University of Rhode Island and the University of Hawaii at Manoa. Based on his educational and professional history in Massachusetts and Rhode Island, he likely follows Boston-area sports.
Unique fact: He led TheracosBio from Phase 1 clinical studies to the successful FDA approval and commercial launch of Brenzavvy™ (bexagliflozin) for type 2 diabetes.
Read the full overview →How Albert shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Albert cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.